Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
4.120
-0.050 (-1.20%)
At close: Nov 22, 2024, 4:00 PM
4.320
+0.200 (4.85%)
After-hours: Nov 22, 2024, 4:20 PM EST
Skye Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 67.41 | 1.26 | 1.24 | 8.98 | 2.47 | 1.83 | Upgrade
|
| Short-Term Investments | - | 0.13 | 0.07 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 67.41 | 1.38 | 1.32 | 8.98 | 2.47 | 1.83 | Upgrade
|
| Cash Growth | 1215.05% | 4.82% | -85.32% | 263.77% | 34.94% | -1.26% | Upgrade
|
| Other Receivables | 0.01 | 0.57 | 0.18 | - | - | - | Upgrade
|
| Receivables | 0.01 | 0.57 | 0.18 | - | - | - | Upgrade
|
| Prepaid Expenses | 0.66 | 0.43 | 0.78 | 0.57 | 0.19 | 0.15 | Upgrade
|
| Restricted Cash | 9.08 | 9.08 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Assets | 2.64 | 0.19 | 6.66 | 0.06 | 0 | 0.01 | Upgrade
|
| Total Current Assets | 79.81 | 11.65 | 8.94 | 9.61 | 2.66 | 1.99 | Upgrade
|
| Property, Plant & Equipment | 1.7 | 0.28 | 0.16 | 0.23 | 0.01 | 0 | Upgrade
|
| Other Long-Term Assets | 0.03 | 0.01 | 0.01 | 0.01 | - | - | Upgrade
|
| Total Assets | 81.54 | 11.94 | 9.11 | 9.86 | 2.67 | 2 | Upgrade
|
| Accounts Payable | 0.78 | 1.16 | 1.79 | 0.9 | 0.36 | 0.13 | Upgrade
|
| Accrued Expenses | 2.97 | 2.07 | 1.12 | 0.9 | 0.32 | 0.43 | Upgrade
|
| Short-Term Debt | - | 4.37 | 0.06 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 1.85 | 1.97 | 0.06 | - | Upgrade
|
| Current Portion of Leases | 0.08 | 0.07 | 0.08 | 0.08 | - | - | Upgrade
|
| Other Current Liabilities | 1.79 | 6.23 | 7.22 | 0.06 | 0.04 | 0.41 | Upgrade
|
| Total Current Liabilities | 5.62 | 13.9 | 12.12 | 3.91 | 0.79 | 0.97 | Upgrade
|
| Long-Term Debt | - | - | - | - | 1.43 | 0.39 | Upgrade
|
| Long-Term Leases | 0.11 | 0.17 | - | 0.08 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0.09 | Upgrade
|
| Total Liabilities | 5.73 | 14.07 | 12.12 | 3.99 | 2.22 | 1.45 | Upgrade
|
| Common Stock | 0.03 | 0.01 | 0 | 0.48 | 0.29 | 0.18 | Upgrade
|
| Additional Paid-In Capital | 196.98 | 102.24 | 63.73 | 52.64 | 38.9 | 32.54 | Upgrade
|
| Retained Earnings | -121.2 | -104.38 | -66.74 | -47.26 | -38.73 | -32.17 | Upgrade
|
| Total Common Equity | 75.8 | -2.13 | -3.01 | 5.86 | 0.45 | 0.55 | Upgrade
|
| Shareholders' Equity | 75.8 | -2.13 | -3.01 | 5.86 | 0.45 | 0.55 | Upgrade
|
| Total Liabilities & Equity | 81.54 | 11.94 | 9.11 | 9.86 | 2.67 | 2 | Upgrade
|
| Total Debt | 0.19 | 4.62 | 1.98 | 2.14 | 1.5 | 0.39 | Upgrade
|
| Net Cash (Debt) | 67.22 | -3.23 | -0.66 | 6.85 | 0.97 | 1.44 | Upgrade
|
| Net Cash Growth | 9504.52% | - | - | 604.71% | -32.66% | 193.03% | Upgrade
|
| Net Cash Per Share | 2.27 | -0.46 | -0.30 | 4.21 | 1.05 | 2.13 | Upgrade
|
| Filing Date Shares Outstanding | 30.34 | 28.06 | 3.89 | 1.98 | 1.4 | 0.73 | Upgrade
|
| Total Common Shares Outstanding | 30.34 | 12.35 | 3.65 | 1.9 | 1.15 | 0.73 | Upgrade
|
| Working Capital | 74.18 | -2.25 | -3.18 | 5.7 | 1.88 | 1.02 | Upgrade
|
| Book Value Per Share | 2.50 | -0.17 | -0.82 | 3.08 | 0.39 | 0.75 | Upgrade
|
| Tangible Book Value | 75.8 | -2.13 | -3.01 | 5.86 | 0.45 | 0.55 | Upgrade
|
| Tangible Book Value Per Share | 2.50 | -0.17 | -0.82 | 3.08 | 0.39 | 0.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.